CARRIE FITZGERALD: Open Payments
NPI 1083361935 · AMHERST, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 48 payments from 16 companies in 2025. Trend: 2023 $596 · 2024 $470 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $168 |
| ABBVIE INC. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| Lilly USA, LLC | 3 | $48 |
| Novo Nordisk Inc | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Esperion Therapeutics, Inc. | 1 | $25 |
Products named: REXULTI, QULIPTA, UBRELVY, PREVNAR 20, ELIQUIS, MOUNJARO, JARDIANCE, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
